Abstract
In-utero exposure to valproic acid (VPA) has been known as a potent inducer of autism spectrum disorder (ASD), not only in humans, but also in animals. In addition to the defects in communication and social interaction as well as repetitive behaviors, ASD patients usually suffer from gastrointestinal (GI) problems. However, the exact mechanism underlying these disorders is not known. In this study, we examined the gross GI tract structure and GI motility in a VPA animal model of ASD. On embryonic day 12 (E12), 4 pregnant Sprague-Dawley (SD) rats were subcutaneously injected with VPA (400 mg/kg) in the treatment group, and with phosphate buffered saline (PBS) in the control group; the resulting male offspring were analyzed at 4 weeks of age. VPA exposure decreased the thickness of tunica mucosa and tunica muscularis in the stomach and ileum. Other regions such as duodenum, jejunum, and colon did not show a significant difference. In high-resolution microscopic observation, atrophy of the parietal and chief cells in the stomach and absorptive cells in the ileum was observed. In addition, decreased staining of the epithelial cells was observed in the hematoxylin and eosin (H&E)-stained ileum section. Furthermore, decreased motility in GI tract was also observed in rat offspring prenatally exposed to VPA. However, the mechanism underlying GI tract defects in VPA animal model as well as the association between abnormal GI structure and function with ASD is yet to be clearly understood. Nevertheless, the results from the present study suggest that this VPA ASD model undergoes abnormal changes in the GI structure and function, which in turn could provide beneficial clues pertaining to the pathophysiological relevance of GI complications and ASD phenotypes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lindhout, D. and Schmidt, D. (1986) In-utero exposure to valproate and neural tube defects. Lancet, 1, 1392–1393.
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B. and Hersh, J.H. (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child. Neurol., 43, 202–206.
Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Yang, S.I., Cheong, J.H., Shin, C.Y. and Ko, K.H. (2011) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett., 201, 137–142.
Schneider, T. and Przewlocki, R. (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology, 30, 80–89.
Valicenti-McDermott, M., McVicar, K., Rapin, I., Wershil, B.K., Cohen, H. and Shinnar, S. (2006) Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J. Dev. Behav. Pediatr., 27, S128–S136.
Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C. and Tildon, J.T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr., 135, 559–563.
Wasilewska, J., Jarocka-Cyrta, E. and Kaczmarski, M. (2009) [Gastrointestinal abnormalities in children with autism]. Pol. Merkuriusz Lek., 27, 40–43.
Wakefield, A.J., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E. and Walker-Smith, J.A. (1998) Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet, 351, 637–641.
Horvath, K. and Perman, J.A. (2002) Autistic disorder and gastrointestinal disease. Curr. Opin. Pediatr., 14, 583–587.
Sousa, I., Clark, T.G., Toma, C., Kobayashi, K., Choma, M., Holt, R., Sykes, N.H., Lamb, J.A., Bailey, A.J., Battaglia, A., Maestrini, E. and Monaco, A.P. (2009) MET and autism susceptibility: family and case-control studies. Eur. J. Hum. Genet., 17, 749–758.
Ashwood, P., Anthony, A., Pellicer, A.A., Torrente, F., Walker-Smith, J.A. and Wakefield, A.J. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol., 23, 504–517.
Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B. and Krajmalnik-Brown, R. (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, e68322.
Baron-Cohen, S. (2002) The extreme male brain theory of autism. Trends Cognit. Sci., 6, 248–254.
Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Park, J.H., Kim, H.J., Jeon, S.J., Dela Pena, I.C., Han, S.H., Cheong, J.H., Ryu, J.H. and Shin, C.Y. (2013) Male-specific alteration in excitatory post-synaptic development and social interaction in prenatal valproic acid exposure model of autism spectrum disorder. J. Neurochem., 124, 832–843.
Mittelstadt, S.W., Hemenway, C.L. and Spruell, R.D. (2005) Effects of fasting on evaluation of gastrointestinal transit with charcoal meal. J. Pharmacol. Toxicol. Methods, 52, 154–158.
Marathe, P.H., Wen, Y., Norton, J., Greene, D.S., Barbhaiya, R.H. and Wilding, I.R. (2000) Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br. J. Clin. Pharmacol., 50, 325–332.
Chaturvedi, A., Kumar, M.M., Bhawani, G., Chaturvedi, H., Kumar, M. and Goel, R.K. (2007) Effect of ethanolic extract of Eugenia jambolana seeds on gastric ulceration and secretion in rats. Indian J. Physiol. Pharmacol., 51, 131–140.
D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E. and Giardini, O. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr., 85, 1076–1079.
Lindstrom, L.H., Nyberg, F., Terenius, L., Bauer, K., Besev, G., Gunne, L.M., Lyrens, S., Willdeck-Lund, G. and Lindberg, B. (1984) CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis. Am. J. Psychiatry, 141, 1059–1066.
Dignass, A.U., Lynch-Devaney, K. and Podolsky, D.K. (1994) Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem. Biophys. Res. Commun., 202, 701–709.
Matsuno, M., Shiota, G., Umeki, K., Kawasaki, H., Kojo, H. and Miura, K. (1997) Induction of plasma hepatocyte growth factor in acute colitis of mice. Inflammation Res., 46, 166–167.
Ido, A., Numata, M., Kodama, M. and Tsubouchi, H. (2005) Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol., 40, 925–931.
Russo, A.J., Krigsman, A., Jepson, B. and Wakefield, A. (2009) Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomarker Insights, 4, 181–190.
Campbell, D.B., Buie, T.M., Winter, H., Bauman, M., Sutcliffe, J.S., Perrin, J.M. and Levitt, P. (2009) Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics, 123, 1018–1024.
Akimoto, M., Baba, A., Ikeda-Matsuo, Y., Yamada, M.K., Ita mura, R., Nishiyama, N., Ikegaya, Y. and Matsuki, N. (2004) Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience, 128, 155–162.
Tyndall, S.J. and Walikonis, R.S. (2006) The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle, 5, 1560–1568.
Gutierrez, H., Dolcet, X., Tolcos, M. and Davies, A. (2004) HGF regulates the development of cortical pyramidal dendrites. Development, 131, 3717–3726.
Ido, A., Numata, M., Kodama, M. and Tsubouchi, H. (2005) Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol, 40, 925–931.
Wakefield, A.J., Anthony, A., Murch, S.H., Thomson, M., Montgomery, S.M., Davies, S., O’Leary, J.J., Berelowitz, M. and Walker-Smith, J.A. (2000) Enterocolitis in children with developmental disorders. Am. J. Gastroenterol, 95, 2285–2295.
Torrente, F., Anthony, A., Heuschkel, R.B., Thomson, M.A., Ashwood, P. and Murch, S.H. (2004) Focal-enhanced gastritis in regressive autism with features distinct from Crohn’ s and Helicobacter pylori gastritis. Am. J. Gastroenterol., 99, 598–605.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, JW., Choi, C.S., Kim, K.C. et al. Gastrointestinal Tract Abnormalities Induced by Prenatal Valproic Acid Exposure in Rat Offspring. Toxicol Res. 29, 173–179 (2013). https://doi.org/10.5487/TR.2013.29.3.173
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2013.29.3.173